WebDisclosure WebDisclosure
Basculer en Français
10827 Companies
234892 Keywords
163751 Articles
125725 Press releases
Headlines Articles Press releases Aurisco Pharmaceutical Remove
  1. Home
  2. Companies
  3. Aurisco Pharmaceutical
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/12/2026 at 21:10, 1 hour 43 minutes ago

    Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide Manufacturer

    Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide TIDES Manufacturing Inclisiran Sodium
  • BRIEF

    published on 08/12/2026 at 21:10, 1 hour 43 minutes ago

    Aurisco Pharmaceutical réussit l'inspection de la FDA américaine en tant que premier fabricant d'oligonucléotides génériques

    Inspection De La FDA Américaine Aurisco Pharmaceutical Inclisiran Sodium Oligonucléotide Générique Fabrication TIDES
  • PRESS RELEASE

    published on 08/12/2026 at 21:05, 1 hour 48 minutes ago

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

    Aurisco Pharmaceutical, a global Oligonucleotide and Peptide manufacturer, becomes the first generic oligonucleotide API manufacturer in the world to pass USFDA inspection. The inspection sets a new standard for safe and affordable oligonucleotides
    Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide Manufacturer Inclusiran Sodium Generic TIDES
    Logo of Aurisco Pharmaceutical
Accesswire
  • Published on 08/12/2026 at 22:01, 52 minutes ago

    Fermi Names Lee McIntire as Chief Executive Officer

  • Published on 08/12/2026 at 15:42, 7 hours 11 minutes ago

    Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results

  • Published on 08/12/2026 at 15:42, 7 hours 11 minutes ago

    Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs

  • Published on 08/12/2026 at 15:00, 7 hours 53 minutes ago

    Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America

  • Published on 08/12/2026 at 14:45, 8 hours 8 minutes ago

    Lobe Sciences Ltd. Announces Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 21:05, 1 hour 48 minutes ago

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

  • Published on 08/12/2026 at 19:57, 2 hours 56 minutes ago

    EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million

  • Published on 08/12/2026 at 19:37, 3 hours 16 minutes ago

    EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged

  • Published on 08/12/2026 at 18:50, 4 hours 3 minutes ago

    Holding(s) in Company

  • Published on 08/12/2026 at 18:29, 4 hours 24 minutes ago

    Designated Persons Notifications

View all EQS
Les Echos
  • Published on 08/11/2026 at 17:45, 1 day 5 hours ago

    DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026

  • Published on 08/11/2026 at 17:40, 1 day 5 hours ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions

  • Published on 08/10/2026 at 18:00, 2 days 4 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 18:00, 2 days 4 hours ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

  • Published on 08/10/2026 at 17:45, 2 days 5 hours ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy